These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

68 related items for PubMed ID: 3895748

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. The influence of ACE-inhibition by captopril on renal formation and metabolism of angiotensins I and II in patients with renovascular hypertension.
    Hesse B, Rasmussen S, Giese J, Nielsen MD, Høilund-Carlsen PF.
    Scand J Urol Nephrol Suppl; 1984; 79():45-8. PubMed ID: 6089318
    [Abstract] [Full Text] [Related]

  • 25. Diagnosis of renovascular hypertension: are i.v. digital subtraction angiography and the excretory urograms really outdated compared to captopril renography?
    Fournier A, Makdassi R, Remond A, Sevestre MA, Clesper PI.
    Nephrol Dial Transplant; 1996 Jun; 11(6):1186-7. PubMed ID: 8966007
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Effect of captopril on arterial pressure, plasma renin activity and the autonomic nervous system in essential arterial hypertension with low-normal plasma renin activity].
    Sturani A, Chiarini C, Degli Esposti E, Gattiani A, Masi A, Santoro A, Umile A, Zuccalà A, Zucchelli P.
    Minerva Nefrol; 1981 Jun; 28(3):265-9. PubMed ID: 7036015
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Assessment of some tests for differentiation of renovascular hypertension from hypertension of other origin.
    Jezersek P, Kaplan S, Sustarsic J, Accetto R, Mihelic-Brcic M.
    Przegl Lek; 1985 Jun; 42(3):313-5. PubMed ID: 3901137
    [No Abstract] [Full Text] [Related]

  • 34. Effect of 12-hour infusions of saralasin or captopril on blood pressure in hypertensive conscious rats. Relationship to plasma renin, duration of hypertension, and effect of unclipping.
    Bing RF, Russell GI, Swales JD, Thurston H.
    J Lab Clin Med; 1981 Aug; 98(2):302-10. PubMed ID: 7019368
    [Abstract] [Full Text] [Related]

  • 35. [Long-term therapeutic efficacy of captopril in the treatment of essential and secondary hypertension].
    Glorioso N, Madeddu P, Dessì Fulgheri P, Oppes M, Tonolo GC, Bandiera F, Manca G, Rappelli A.
    Minerva Cardioangiol; 1984 Aug; 32(7-8):467-71. PubMed ID: 6387536
    [No Abstract] [Full Text] [Related]

  • 36. [Diagnostic and therapeutic aspects in renovascular hypertension].
    Cinotti GA.
    Cardiologia; 1985 Nov; 30(11):999-1000. PubMed ID: 3914918
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [New differential diagnostic and therapeutic possibilities in arterial hypertension].
    Gogin EE, Gerasimov GM, Martyniuk AD.
    Klin Med (Mosk); 1978 Oct; 56(10):30-5. PubMed ID: 713456
    [No Abstract] [Full Text] [Related]

  • 39. Inadequacy of captopril challenge test for diagnosing renovascular hypertension in children and adolescents.
    Gauthier B, Trachtman H, Frank R, Pillari G.
    Pediatr Nephrol; 1991 Jan; 5(1):42-4. PubMed ID: 2025535
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.